Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

mTOR inhibitors: an overview.

P Neuhaus1, J Klupp, J M Langrehr

  • 1Department of Surgery, Charité Virchow, Berlin, Germany. chirurgie@charite.de

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|July 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: a model-based approach.

Clinical pharmacology and therapeutics·2015
Same author

Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

[Metastatic lesions to the pancreas. When is resection reasonable?].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2007
Same author

[Carcinoma of the pancreas: summary of guidelines 2007, issued jointly by 15 German specialist medical societies].

Deutsche medizinische Wochenschrift (1946)·2007
Same journal

Effect of postoperative synbiotics on bacterial infections after liver transplantation: A randomized double-blind placebo-controlled trial.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Long-term renal benefit of a biopsy-guided personalized calcineurin inhibitor-sparing regimen late after liver transplantation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

REPLY: From detecting sarcopenia to guiding intervention-should bedside muscle assessment in cirrhosis be function-oriented rather than mass-oriented?

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Letter to the Editor: From detecting sarcopenia to guiding intervention-should bedside muscle assessment in cirrhosis be function-oriented rather than mass-oriented?

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Pre-transplant lipase elevation: A single-center study of clinically significant pancreatitis in liver transplant candidates.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Can FMN even the playing field? mitochondrial FMN during hypothermic oxygenated perfusion to guide liver utilization.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
See all related articles

Mammalian target of rapamycin inhibitors offer a novel approach to immunosuppression, distinct from calcineurin inhibitors. Their unique mechanism shows promise in preventing allograft rejection and inducing tolerance in transplantation.

Area of Science:

  • Immunology
  • Pharmacology
  • Transplantation Medicine

Background:

  • Mammalian target of rapamycin (mTOR) inhibitors represent a new class of immunosuppressants.
  • Unlike tacrolimus and cyclosporine A, mTOR inhibitors do not target calcineurin, affecting T-cell activation differently.
  • Sirolimus (rapamycin) and its derivative RAD possess distinct mechanisms of action and side effect profiles.

Purpose of the Study:

  • To review preclinical and clinical findings on mTOR inhibitors in transplantation.
  • To explore the potential of sirolimus and RAD in managing allograft rejection and inducing tolerance.
  • To highlight the distinct pharmacological properties of mTOR inhibitors compared to other immunosuppressants.

Main Methods:

  • Review of published preclinical studies.

Related Experiment Videos

  • Analysis of clinical trial data.
  • Comparison of mTOR inhibitor mechanisms with established immunosuppressants.

    • Main Results:

    • mTOR inhibitors demonstrate synergism with cyclosporine A and tacrolimus.
    • These agents show potential for preventing chronic allograft rejection and avoiding nephrotoxicity.
    • Ongoing studies are investigating their role in tolerance induction.

    Conclusions:

    • mTOR inhibitors offer a promising new strategy in immunosuppression for transplantation.
    • Their unique mechanism and potential benefits warrant further clinical investigation.
    • Sirolimus and RAD are expected to play a significant role in future transplantation protocols.